ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,717Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 252

$731K Total Retail Price of All Prescriptions

Rank: 43 out of 252

464 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 12,963 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 669 585 1 1
FUROSEMIDE 552 449 2 7
POTASSIUM CHLORIDE 429 361 3 8
GABAPENTIN 395 301 4 11
ATENOLOL 394 316 5 18
OMEPRAZOLE 375 305 6 6
WARFARIN SODIUM 327 264 7 14
HYDROCODONE-ACETAMINOPHEN 327 262 S3 7 5
NAMENDA 309 303 9 41
AMLODIPINE BESYLATE 302 289 10 4
LISINOPRIL 258 245 11 3
SERTRALINE HCL 226 182 12 27
TRIAMTERENE-HCTZ 224 195 13 33
METFORMIN HCL 216 166 14 9
METOPROLOL TARTRATE 203 182 15 10
ALLOPURINOL 179 162 16 30
GLIPIZIDE 171 133 17 52
PRAVASTATIN SODIUM 161 117 18 12
AMITRIPTYLINE HCL 154 91 R 19 46
CEPHALEXIN 146 124 20 121
PREDNISONE 139 128 21 42
TRAMADOL HCL 137 86 22 17
SIMVASTATIN 136 132 23 2
MELOXICAM 135 108 24 20
DONEPEZIL HCL 135 125 24 28
TAMSULOSIN HCL 132 102 26 26
RANITIDINE HCL 131 97 27 48
TERAZOSIN HCL 131 113 27 94
CIPROFLOXACIN HCL 128 112 29 61
HYDROCHLOROTHIAZIDE 127 124 30 13
METOPROLOL SUCCINATE 118 115 31 19
NEXIUM 114 78 32 23
RISPERIDONE 112 91 33 81
GEMFIBROZIL 109 85 34 98
ESCITALOPRAM OXALATE 104 83 35 56
CLONIDINE HCL 102 78 36 35
ZOLPIDEM TARTRATE 101 67 37 21
FLUTICASONE PROPIONATE 101 86 37 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 94 39 25
ENALAPRIL MALEATE 98 84 39 72
CLOPIDOGREL 95 87 41 29
CARVEDILOL 94 84 42 22
PROPRANOLOL HCL 93 75 43 111
CITALOPRAM HBR 91 78 44 15
AZITHROMYCIN 90 76 45 37
DIGOXIN 89 86 46 44
FINASTERIDE 88 72 47 115
TRAZODONE HCL 87 82 48 31
SULFAMETHOXAZOLE-TRIMETHOPRIM 86 71 49 87
NIFEDIPINE ER 85 73 50 108
OXYBUTYNIN CHLORIDE 84 69 51 123
ISOSORBIDE MONONITRATE ER 83 71 52 50
PANTOPRAZOLE SODIUM 82 69 53 62
MIRTAZAPINE 81 81 54 58
LAMOTRIGINE 79 69 55 165
ACETAMINOPHEN-CODEINE 77 65 S3 56 117
TORSEMIDE 77 76 56 214
LANTUS 77 57 56 55
ATORVASTATIN CALCIUM 71 46 59 16
AMOX TR-POTASSIUM CLAVULANATE 71 55 59 132
NADOLOL 70 62 61 207
PAROXETINE HCL 70 60 61 75
PENTOXIFYLLINE 69 67 63 313
LYRICA 69 51 63 66
FAMOTIDINE 68 68 65 59
RAMIPRIL 67 64 66 71
SOTALOL 64 59 67 205
DILTIAZEM HCL 64 46 67 177
FLUOXETINE HCL 60 35 69 57
BUSPIRONE HCL 60 54 69 119
METOCLOPRAMIDE HCL 60 47 69 110
PROAIR HFA 59 30 72 54
CARBIDOPA-LEVODOPA 59 46 72 107
CYCLOBENZAPRINE HCL 57 11 R 74 51
PLAVIX 57 57 74 43
MECLIZINE HCL 55 55 76 136
NAPROXEN 53 42 77 96
CARISOPRODOL 52 13 R 78 70
DOXYCYCLINE HYCLATE 52 35 78 92
POLYETHYLENE GLYCOL 3350 51 51 80 67
CRESTOR 50 49 81 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.